Clinical Trials Logo

Hepatomegaly clinical trials

View clinical trials related to Hepatomegaly.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT02298699 Withdrawn - Developmental Delay Clinical Trials

Biomarker for Sly Disease (MPS VII) (BioSly)

BioSly
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new MS-based biomarker for the early and sensitive diagnosis of Sly disease from blood (plasma)

NCT ID: NCT02298634 Withdrawn - Splenomegaly Clinical Trials

Biomarker for Farber Disease (BioFarber)

BioFarber
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new mass spectrometry-based biomarker for the early and sensitive diagnosis of Farber disease from the blood

NCT ID: NCT01331642 Withdrawn - Splenomegaly Clinical Trials

Biomarker for Gaucher Disease: BioGaucher (BioGaucher)

BioGaucher
Start date: August 20, 2018
Phase:
Study type: Observational

Development of a new mass spectrometry-based biomarker for the early and sensitive diagnosis of Gaucher Disease from blood (plasma)